In the context of hemochromatosis, it remains to be established how the systemic and cardiac hepcidin/ferroportin axes interact, and the extent to which local iron regulation in the heart mitigates against or exacerbates iron overload cardiomyopathy. The gene discussed is HAMP; the disease is hemochromatosis.